1281637: ADENOVIRUS TYPE 4 AND TYPE 7 VAC.
ADENOVIRUS TYPE 4 AND TYPE 7 VAC. Key specifications include part_name_assigned_by_controlling_agency: ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-642-0106, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S |
| NSN | 6505-01-642-0106 |
| SPECIAL FEATURES | CONTAINS VIABLE, SELECTED STRAINS OF HUMAN ADENOVIRUS TYPE 4 AND HUMAN ADENOVIRUS TYPE 7 PREPARED IN HUMAN-DIPLOID FIBROBLAST CELL CULTURES (STRAIN WI-38); VIRUS STRAINS HAVE NOT BEEN ATTENUATED; CELLS ARE GROWN AND THE VIRUS GROWTH MAINTAINED IN DULBECCO'S MODIFIED EAGLE'S MEDIUM, FETAL BOVINE SERUM, AND SODIUM BICARBONATE; APPROVED FOR USE IN MILITARY POPULATIONS 17-50 YEARS OF AGE; INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF FEBRILE ACUTE RESPIRATORY DISEASE CAUSED BY ADENOVIRUS TYPE 4 AND TYPE 7; CARTON CONSISTS OF ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 4 (NDC 51285-174-02) AND ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 7 (NDC 51285-175-02); STORE REFRIGERATED BETWEEN 2-8 DEG C (35-46 DEG F); DO NOT FREEZE; KEEP BOTTLE TIGHTLY CLOSED AND PROTECT FROM MOISTURE; DO NOT REMOVE DESICCANT CANISTER FROM BOTTLE; PRESCRIPTION ONLY; FOR ORAL ADMINISTRATION; DOSAGE: ONE TABLET OF ADENOVIRUS TYPE 4 COMPONENT AND ONE TABLET OF ADENOVIRUS TYPE 7 COMPONENT DEGC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S |